Ranitidine Hydrochloride

CAS 66357-59-3 14 FDA-DMF suppliersSmall Molecule

Overview

Ranitidine Hydrochloride is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used to treat and prevent ulcers in the stomach and intestines, and conditions such as gastroesophageal reflux disease.

API suppliers (11)

Suppliers of Ranitidine Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • SHANGHAI NO 6 PHARMACEUTICAL FACTORY
  • QUIMICA SINTETICA SASpain
  • PHARMAGLOBE LABORATORIES LTD
  • RANBAXY LABORATORIES LTD
  • CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
  • MAPRIMED SA
  • Wockhardt LimitedIndia
  • SHASUN CHEMICALS AND DRUGS LTD
  • SOLARA ACTIVE PHARMA SCIENCES LTD
  • FARCHEMIA SRL
  • JBC Pharmaceuticals Ltd.United Kingdom

Chemical identity

IUPAC name
1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
Canonical SMILES
CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C
InChIKey
VMXUWOKSQNHOCA-UHFFFAOYSA-N

Therapeutic areas

Gastrointestinal DisordersPeptic UlcerGastroesophageal Reflux Disease

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.